Literature DB >> 19947988

CRP gene variation and risk of community-acquired pneumonia.

Kenneth J Mukamal1, Jennifer K Pai, Ellen S O'Meara, Russell P Tracy, Bruce M Psaty, Lewis H Kuller, Anne B Newman, Sachin Yende, Gary C Curhan, David S Siscovick, Eric B Rimm.   

Abstract

BACKGROUND AND
OBJECTIVE: CRP has several potentially antibacterial effects, and variation in the CRP gene is known to influence CRP levels. Whether this variation influences risk of infection, and hence whether CRP has anti-infective activity in humans, is uncertain.
METHODS: We evaluated a series of haplotype-tagging single nucleotide polymorphisms among 5374 individuals in the Cardiovascular Health Study, a cohort of older adults from four communities, who were followed for community-acquired pneumonia for 12-13 years. Secondarily, we evaluated whether these polymorphisms varied among men in the Health Professionals Follow-up Study who self-reported pneumonia on biennial questionnaires.
RESULTS: There were 581 (507 white and 74 black) Cardiovascular Health Study participants with incident hospitalizations for pneumonia. No single nucleotide polymorphism or haplotypes were associated with risk among white Cardiovascular Health Study participants. Among black participants, the haplotype tagged by A790T was associated with lower risk of incident pneumonia (hazard ratio 0.5; 95% confidence interval: 0.3-0.9) and with higher CRP levels. In Health Professionals Follow-up Study, a separate haplotype was associated with less frequent self-reported pneumonia but not with circulating CRP levels.
CONCLUSIONS: Some genetic variants in CRP may be associated with risk of pneumonia, but haplotypes associated with risk are variably associated with baseline CRP levels. If CRP is a relevant component of innate immunity in humans, the inducibility or tissue-specificity of expression may be at least as important as chronic circulating levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19947988      PMCID: PMC2869386          DOI: 10.1111/j.1440-1843.2009.01661.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  34 in total

1.  Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.

Authors:  Peter Kraft; David G Cox; Randi A Paynter; David Hunter; Immaculata De Vivo
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

2.  An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.

Authors:  N H Ng'andu
Journal:  Stat Med       Date:  1997-03-30       Impact factor: 2.373

Review 3.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.

Authors:  Nicolas W J Schröder; Ralf R Schumann
Journal:  Lancet Infect Dis       Date:  2005-03       Impact factor: 25.071

4.  Enhanced preoperative C-reactive protein plasma levels as a risk factor for postoperative infections after cardiac surgery.

Authors:  E J Fransen; J G Maessen; T W Elenbaas; E E van Aarnhem; M P van Dieijen-Visser
Journal:  Ann Thorac Surg       Date:  1999-01       Impact factor: 4.330

5.  Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus.

Authors:  P Garred; H O Madsen; P Halberg; J Petersen; G Kronborg; A Svejgaard; V Andersen; S Jacobsen
Journal:  Arthritis Rheum       Date:  1999-10

6.  Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease.

Authors:  Thomas R Hawn; Annelies Verbon; Marta Janer; Lue Ping Zhao; Bruce Beutler; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

7.  Expression of C-reactive protein by alveolar macrophages.

Authors:  Q Dong; J R Wright
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  C-reactive protein as an indicator of sepsis.

Authors:  P Póvoa; E Almeida; P Moreira; A Fernandes; R Mealha; A Aragão; H Sabino
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

9.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.

Authors:  B M Psaty; L H Kuller; D Bild; G L Burke; S J Kittner; M Mittelmark; T R Price; P M Rautaharju; J Robbins
Journal:  Ann Epidemiol       Date:  1995-07       Impact factor: 3.797

10.  Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations.

Authors:  U Boeken; P Feindt; N Zimmermann; G Kalweit; T Petzold; E Gams
Journal:  Eur J Cardiothorac Surg       Date:  1998-05       Impact factor: 4.191

View more
  3 in total

1.  CYP1A1, GCLC, AGT, AGTR1 gene-gene interactions in community-acquired pneumonia pulmonary complications.

Authors:  Lyubov E Salnikova; Tamara V Smelaya; Arkadiy M Golubev; Alexander V Rubanovich; Viktor V Moroz
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

2.  C-reactive protein is essential for innate resistance to pneumococcal infection.

Authors:  J Paul Simons; Jutta M Loeffler; Raya Al-Shawi; Stephan Ellmerich; Winston L Hutchinson; Glenys A Tennent; Aviva Petrie; John G Raynes; J Brian de Souza; Rachel A Lawrence; Kevin D Read; Mark B Pepys
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 3.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.